首页 | 本学科首页   官方微博 | 高级检索  
     


Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2000). I. Susceptibility distribution
Authors:Kumamoto Yoshiaki  Tsukamoto Taiji  Fujime Makoto  Fujita Kazuhiko  Hirose Takaoki  Matsukawa Masanori  Takahashi Satoshi  Kunishima Yasuharu  Igari Jun  Ogihara Masahiko  Ishibashi Kei  Oguri Toyoko  Shigeta Shiro  Yamaguchi Keizo  Matsumoto Tetsuya  Kashitani Fusako  Yoshida Hiroshi  Imafuku Yuuji  Murai Masaru  Ooe Hiroshi  Nishikawa Mineko  Watanabe Kiyoaki  Kobayashi Yoshio  Uchida Hiroshi  Oka Toshitsugu  Kitamura Masaya  Takano Yuuji  Matsuoka Yasuhiro  Matsuda Seiji  Sato Shinichi  Furuhama Toshinari  Kumon Hiromi  Monden Koichi  Aoki Siho  Mochida Chikako  Hirakata Yoichi  Kohno Shigeru  Miyazaki Yoshitsugu
Affiliation:Department of Urology, Sapporo Medical University, School of Medicine.
Abstract:The bacterial strains isolated from patients diagnosed as having urinary tract infections (UTIs) in 10 institutions in Japan were supplied between the period of August 2000 and July 2001. Then, the susceptibilities of them to many kinds of antimicrobial agents were investigated. The number of them were 511 strains. The breakdown of these strains was Gram-positive bacteria as 29.0% and Gram-negative bacteria as 71.0%. Susceptibilities of these bacteria to antimicrobial agents were as follows; vancomycin (VCM), ampicillin (ABPC) and imipenem (IPM) showed strong activities against Enterococcus faecalis. No increase in low-susceptible strains of E. faecalis observed against these antimicrobial agents. VCM showed a strong activity against MRSA preventing growth of all strains with 1 microgram/ml. In addition, the activity of arbekacin (ABK) was strong with the MIC90 of 2 micrograms/ml against MRSA and prevented growth of all strains with 4 micrograms/ml. ABK showed a strong activity against Staphylococcus epidermidis preventing growth of all strains with 0.5 microgram/ml. ABPC, cefotiam (CTM) and cefozopran (CZOP) also showed a relatively strong activity against S. epidermidis (MIC90: 4 to 8 micrograms/ml). Against Escherichia coli, carbapenems showed high activities: meropenem (MEPM) prevented growth of all strains within 0.125 microgram/ml; IPM prevented growth of all strains with 0.25 microgram/ml. CZOP and CTM also showed strong activities against E. coli: MIC90 of CZOP was within 0.125 microgram/ml; MIC80 and MIC90 of CTM were 0.25 and 0.5 microgram/ml, respectively. Quinolone resistant E. coli was detected at frequency of 14.0%, which was significantly higher than that in the last year. Almost all drugs showed strong activities against Klebsiella pneumoniae and Proteus mirabilis, and MEPM prevented growth of all strains within 0.125 microgram/ml. Against Pseudomonas aeruginosa, almost drugs were not so active. The MIC90 of carbapenems and gentamicin (GM) were 16 micrograms/ml and those of all other drugs were more than 32 micrograms/ml. Against Serratia marcescens, the MIC90 of IPM and GM were the lowest value being 2 micrograms/ml, and that of MEPM was 4 micrograms/ml.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号